Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

St. Olavs Hospital HF
Sponsor

St. Olavs Hospital HF

Norway Prinsesse Kristinas G. 3, 7030 Trondheim, Norway

About the sponsor

Research activity includes chronic cluster headache, episodic cluster headache, chronic migraine, and episodic migraine, with interest in preventive and symptom-targeted treatment approaches.

  • Cluster headache
  • Migraine prophylaxis
  • Neurovascular pain disorders

The portfolio also reflects work on treatment-resistant headache syndromes and intervention strategies aimed at reducing attack frequency and disability.

About Specializations

St. Olavs Hospital HF runs clinical trials in conditions such as Migraine, Cluster headache, Type 1 diabetes mellitus, Testicular seminoma (pure) stage I, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

17 clinical trials

Testicular seminoma (pure) stage I

Recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Bleomycin
  • Sponsor:St. Olavs Hospital HF

Wheezing+1

Recruiting
Registered drug
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Betamethasone Sodium Phosphate
  • Sponsor:St. Olavs Hospital HF

Colorectal cancer metastatic

Recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Oxaliplatin
  • Sponsor:St. Olavs Hospital HF

Post procedural complication

Recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:St. Olavs Hospital HF

Migraine

Recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Atorvastatin
  • Sponsor:St. Olavs Hospital HF

Migraine

Recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Atorvastatin
  • Sponsor:St. Olavs Hospital HF

Retinopathy of prematurity

Not yet recruiting
Registered drug
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Dexmedetomidine
  • Sponsor:St. Olavs Hospital HF

Cluster headache

Not yet recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Candesartan
  • Sponsor:Helse Bergen HF

Cluster headache

Not yet recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Candesartan
  • Sponsor:Helse Bergen HF

Type 1 diabetes mellitus

Not yet recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Glucagon
  • Sponsor:St. Olavs Hospital HF

Migraine

Not yet recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Atorvastatin
  • Sponsor:St. Olavs Hospital HF

Migraine

Not yet recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Atorvastatin
  • Sponsor:St. Olavs Hospital HF

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.